SREDX Personas

Background: R&D manager at a mid-sized manufacturing company.

Needs: Reliable R&D outcomes to propose new products and improve processes.

Pain Points: Faced with skepticism from management about R&D costs and returns.

Why "Result or No Cost": Irene can justify R&D expenses to her superiors with a results-based costing model, strengthening her position and potentially her company's competitiveness.

Background: Founder of a tech startup, operating on a tight budget with limited access to upfront capital.

Needs: Cost-effective R&D solutions, with financial predictability to maintain cash flow.

Pain Points: Cannot afford to invest in R&D without guaranteed results, wary of unforeseen expenses.

Why "Result or No Cost": Steve's startup can engage in R&D without the financial risk, ensuring he only pays if the SR&ED service yields results.

Background: Lead researcher at a biotech firm, focused on groundbreaking medical discoveries.

Needs: Access to advanced research methods and technologies without compromising her budget.

Pain Points: Frustrated by the limitation of funds which hampers her ability to conduct potentially revolutionary experiments.

Why "Result or No Cost": Rachel can pursue ambitious research projects knowing that she won't deplete her resources on fruitless endeavors.

Background: Chief Financial Officer for a large enterprise, responsible for budgeting and cost management.

Needs: To allocate funds efficiently and reduce wasteful spending.

Pain Points: Concerned about the impact of unproductive R&D on the company’s financials.

Why "Result or No Cost": Fiona can adopt an SR&ED service that aligns with her fiscal prudence, offering a no-risk investment in innovation.

Background: Serial entrepreneur with multiple ventures, always looking for the next big innovation.

Needs: A quick turnaround on R&D to stay ahead in fast-paced markets.

Pain Points: Traditional R&D investment models are too slow and uncertain for his dynamic business style.

Why "Result or No Cost": Eric benefits from aligning R&D costs directly with successful outcomes, allowing him to pivot rapidly and efficiently.